Summary
Molbio Diagnostics IPO allotment is expected on Thursday, following a 70.26 times subscription for the Rs 939.70-crore issue. With a 20% grey market premium, investors await results before the August 17 listing, with proceeds funding R&D and manufacturing expansion.